Dopamine system stabilizers, aripiprazole, and the next generation of antipsychotics, Part 2 - Illustrating their mechanism of action

被引:113
作者
Stahl, SM
机构
[1] Neurosci Educ Inst, Carlsbad, CA 92009 USA
[2] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA
关键词
D O I
10.4088/JCP.v62n1201
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
引用
收藏
页码:923 / 924
页数:2
相关论文
共 9 条
[1]  
ANDREE TH, 1999, 38 ANN M AM COLL NEU
[2]  
BURRIS KD, 2000, 22 ANN M C COLL INT
[3]   Neurotransmitter interactions in schizophrenia - Therarpeutic implications [J].
Carlsson, A ;
Waters, N ;
Carlsson, ML .
BIOLOGICAL PSYCHIATRY, 1999, 46 (10) :1388-1395
[4]   (-)-OSU 6162 inhibits levodopa-induced dyskinesias in a monkey model of Parkinson's disease [J].
Ekesbo, A ;
Andren, PE ;
Gunne, LM ;
Tedroff, J .
NEUROREPORT, 1997, 8 (11) :2567-2570
[5]   Antipsychotic properties of the partial dopamine agonist (-)-3-(3-hydroxyphenyl)-N-n-propylpiperidine (preclamol) in schizophrenia [J].
Lahti, AC ;
Weiler, MA ;
Corey, PK ;
Lahti, RA ;
Carlsson, A ;
Tamminga, CA .
BIOLOGICAL PSYCHIATRY, 1998, 43 (01) :2-11
[6]   Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes [J].
Lawler, CP ;
Prioleau, C ;
Lewis, MM ;
Mak, C ;
Jiang, D ;
Schetz, JA ;
Gonzalez, AM ;
Sibley, DR ;
Mailman, RB .
NEUROPSYCHOPHARMACOLOGY, 1999, 20 (06) :612-627
[7]   Dopamine system stabilizers, aripiprazole, and the next generation of antipsychotics, Part 1 - "Goldilocks" actions at dopamine receptors [J].
Stahl, SM .
JOURNAL OF CLINICAL PSYCHIATRY, 2001, 62 (11) :841-842
[8]  
TORU M, 1994, NEUROPSYCHOPHARMACOL, V10, pS122
[9]  
VANVLIET BJ, 2000, 13 ANN M EUR COLL NE